IRIS UniCatt

Lopetuso, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.625
AS - Asia 3.736
EU - Europa 3.577
SA - Sud America 906
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
Totale 12.960
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.432
SG - Singapore 1.810
CN - Cina 959
SE - Svezia 766
IT - Italia 757
BR - Brasile 746
DE - Germania 691
FR - Francia 310
IE - Irlanda 210
VN - Vietnam 203
GB - Regno Unito 197
ID - Indonesia 139
IN - India 139
UA - Ucraina 133
FI - Finlandia 126
PL - Polonia 117
CA - Canada 96
RU - Federazione Russa 85
HK - Hong Kong 71
MX - Messico 69
AR - Argentina 68
TR - Turchia 66
BD - Bangladesh 54
JP - Giappone 52
KR - Corea 45
ZA - Sudafrica 40
IQ - Iraq 33
BE - Belgio 30
NL - Olanda 28
IR - Iran 27
EC - Ecuador 26
ES - Italia 26
UZ - Uzbekistan 17
EG - Egitto 16
CL - Cile 15
CO - Colombia 14
PK - Pakistan 14
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 12
AT - Austria 11
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
CI - Costa d'Avorio 10
EU - Europa 10
KE - Kenya 10
VE - Venezuela 10
JO - Giordania 9
PE - Perù 9
JM - Giamaica 8
LT - Lituania 8
NP - Nepal 8
PY - Paraguay 8
RO - Romania 8
MA - Marocco 7
RS - Serbia 7
GR - Grecia 6
OM - Oman 6
AL - Albania 5
BG - Bulgaria 5
IL - Israele 5
TH - Thailandia 5
TN - Tunisia 5
BH - Bahrain 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
LV - Lettonia 4
NO - Norvegia 4
PH - Filippine 4
TW - Taiwan 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AU - Australia 2
CR - Costa Rica 2
GY - Guiana 2
KH - Cambogia 2
KZ - Kazakistan 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
PA - Panama 2
SN - Senegal 2
A1 - Anonimo 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
Totale 12.936
Salva come PNG Salva come JPEG
Città #
Singapore 881
Chandler 817
Ashburn 481
Beijing 265
Dublin 200
New York 179
Los Angeles 155
Jakarta 123
Cattolica 114
Rome 110
Boston 105
Ann Arbor 93
San Mateo 90
Hefei 88
Warsaw 88
Munich 86
Jacksonville 84
Wilmington 83
Milan 81
Dallas 76
Ho Chi Minh City 73
Princeton 73
São Paulo 72
Fairfield 71
Nanjing 68
Houston 65
Marseille 61
Hong Kong 60
Woodbridge 53
Moscow 52
Seattle 52
Frankfurt am Main 51
The Dalles 51
Dearborn 50
Hanoi 50
Hangzhou 45
Helsinki 45
Redwood City 42
Tokyo 42
Izmir 39
London 39
Chicago 37
Seoul 35
North Bergen 32
Nuremberg 31
Montreal 30
Santa Clara 30
Stockholm 30
Shanghai 29
Buffalo 28
Chennai 28
Lawrence 28
Turku 28
Bremen 27
Brussels 27
Guangzhou 27
Boardman 26
Augusta 25
Brooklyn 24
Johannesburg 24
Denver 23
Lappeenranta 23
Shenyang 23
Atlanta 22
Kent 22
Pune 22
Rio de Janeiro 22
Lancaster 21
Nürnberg 21
Poplar 21
Redmond 21
Tianjin 21
Phoenix 20
Andover 19
Mexico City 19
Nanchang 19
San Francisco 19
Toronto 18
Belo Horizonte 17
Cambridge 17
Norwalk 17
Jiaxing 16
Kraków 16
Hebei 15
Hyderabad 15
Manchester 15
Baghdad 14
Curitiba 14
Da Nang 14
Guayaquil 14
Zhengzhou 14
Düsseldorf 13
Kunming 13
Lauterbourg 13
Mountain View 13
Porto Alegre 12
Changsha 11
Fremont 11
Guarulhos 11
Kish 11
Totale 6.581
Salva come PNG Salva come JPEG
Nome #
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 292
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 238
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 223
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 200
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 196
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 190
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 185
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 181
The gut barrier: new acquisitions and therapeutic approaches 177
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 176
13C-octanoic acid breath test to study gastric emptying time 171
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 165
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 164
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 151
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 147
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 144
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 143
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 141
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 140
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 139
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 131
The gastrointestinal microbiome - functional interference between stomach and intestine 130
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 129
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 129
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 128
Development and validation of predictive assessment of complicated diverticulitis score 128
The use of probiotics in different phases of diverticular disease 125
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 124
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 123
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 121
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 116
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 115
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 115
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 115
Commensal Clostridia: leading players in the maintenance of gut homeostasis 114
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 113
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 112
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 112
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 111
Bacillus clausii and gut homeostasis: state of the art and future perspectives 111
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 111
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 110
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 108
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 108
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 106
Gut microbiota and inflammatory bowel disease: an update 105
Can we predict the efficacy of anti-TNF-α agents? 103
Digital integration between hospitals and local health authorities for enhanced vaccination coverage among frail patients: the CareVax study protocol 103
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 102
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 101
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 101
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 98
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 98
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 97
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 97
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 96
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 96
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 96
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 94
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 94
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 94
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 92
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 92
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 92
Radiomics could predict surgery at 10 years in Crohn's disease 91
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 90
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 90
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 89
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 88
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 88
Microbiota Composition in Diverticular Disease: Implications for Therapy 87
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 87
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 87
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 86
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 86
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 84
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 83
Microbiota Composition in Diverticular Disease: Implications for Therapy 82
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 82
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 81
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 80
[Ulcerative colitis] 79
Relationship between oral microbiota and periodontal disease: a systematic review 79
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 79
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 79
Gut Virome and Inflammatory Bowel Disease 78
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 78
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 78
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 77
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 76
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 75
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 75
Bariatric procedures and microbiota: patient selection and outcome prediction 75
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 74
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 74
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 74
Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations 73
Endoscopic Management of Strictures in Crohn’s Disease: An Unsolved Case 72
Orphan patients with inflammatory bowel disease - when we treat beyond evidence 71
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 70
Totale 11.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 0 54 50 14 59 37 128 28
2021/2022949 93 35 23 66 70 25 12 135 48 94 180 168
2022/20232.198 311 305 164 346 135 248 103 176 239 35 75 61
2023/20241.220 76 313 54 74 42 171 79 49 54 43 123 142
2024/20252.476 59 74 206 61 179 84 118 103 328 292 518 454
2025/20263.927 985 194 388 864 1.232 264 0 0 0 0 0 0
Totale 13.150